Related Experiment Videos
[Current trends in infection imaging]
Trifon Spyridonidis1, Pavlos Markou
1Nuclear Medicine Physician, Nuclear Medicine Department, Rio Central Hospital, Rio, Patra, Greece. tspyr@med.upatras.gr.
Hellenic Journal of Nuclear Medicine
|May 12, 2005
Summary
Nuclear medicine offers vital infection imaging techniques, aiding diagnosis and patient outcomes. Ongoing research explores new agents like labeled antimicrobials and FDG-PET for improved accuracy in detecting infections.
Area of Science:
- Medical imaging
- Nuclear medicine
- Infection diagnosis
Background:
- Infection remains a significant cause of morbidity and mortality despite medical advances.
- Nuclear medicine plays a crucial role in infection imaging, complementing other modalities or serving as the primary choice in specific cases like orthopedic infections.
Purpose of the Study:
- To review current nuclear medicine agents used for infection imaging.
- To discuss the advantages and disadvantages of various agents.
- To highlight emerging methods in infection imaging.
Main Methods:
- Review of existing literature on nuclear medicine agents for infection imaging.
- Discussion of established and novel radiopharmaceuticals.
- Inclusion of positron emission tomography (PET) with fluorodeoxyglucose (FDG).
Main Results:
- Multiple nuclear medicine agents are available for infection imaging, each with unique benefits and limitations.
- Established agents are valuable in specific clinical scenarios, such as postoperative and orthopedic infections.
- Emerging techniques, including labeled antibacterial agents, antimicrobial peptides, monoclonal antibodies, liposomes, and (18)F-FDG-PET, show promise.
Conclusions:
- Nuclear medicine is indispensable for infection imaging.
- A variety of agents exist, with ongoing research focused on developing more effective and targeted imaging methods.
- Newer agents and techniques like (18)F-FDG-PET are expanding the capabilities of nuclear medicine in diagnosing and managing infections.